BRCA1 and cancer: Previous studies have attempted to predict BRCA1/2 mutation carriers based on clinical information, such as age, gender and family history of cancer, but achieved limited predictive performance.[10] Recent efforts to incorporate detailed pathological features into phenotype‐driven prediction models have demonstrated higher accuracy in Asian populations.[3, 10] This improved performance has shifted the focus of screening methods to pathological image‐based models, particularly given the well‐established genotype‐phenotype correlations in breast cancer.